Chicago Business
Chicago Business

Tide is turning on AbbVie's Humira

Tide is turning on AbbVie's Humira

Having trouble viewing this email? See the online version

Health Pulse Breaking News
Tuesday, April 16, 2024
Abbvie's Humira pen

With CVS cost-cutting move, AbbVie's Humira dam begins to crack

AbbVie’s blockbuster drug managed to hang on to most of its market in the first year it faced biosimilar competition, but the tide appears to be turning.
 
Read More >

Did someone forward this to you? Sign up for Health Pulse breaking news alerts here and unlock access to the full story with a Health Pulse subscription.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

<![if !mso]> <![endif]>
VIEW OUR SUBSCRIPTION OFFERS
 

This email was sent to chicagobusinessus627@emails.newslettersbase.com
Manage My Account | Contact Us
 

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

 
  • This email was sent

    April 16, 2024 7:20pm

  • Country:

    United States

  • Tags
Prev Newsletter Next Newsletter